ENDOCRINE EVALUATION OF ATHLETE FOR TESTOSTERONE OR ITS ANALOGUES ABUSE

  • Joško Osredkar Klinični inštitut za klinično kemijo in biokemijo Klinični center Njegoševa 4 1525 Ljubljana
Keywords: doping, T/E ratio, ketoconazol, list of prohibited substances

Abstract

Background. Doping involves the use of substances and methods prohibited by international and national sports institutions. The use of certain substances and methods is harmful to the human organism, so all sports organisations are trying to protect athletes from the harmful side effects of such substances and methods.

Methods. The article deals with special protocol, which is used in the case, when the testosterone/epitestosterone ratio in urine is higher than 6 and less then 10. When establishing the use of testosterone or analogues, ketoconazol is used. If after the application the presence of a testosterone (T) to epitestosterone (E) ratio is greater than six (6) to one (1), there is an evidence of doping offence.

Conclusions. In the case of T/E greater than 6, it is mandatory that the relevant medical authority conducts an investigation before the sample is declared positive. A full report should be written and should include a review of previous tests, subsequent tests and any results of endocrine investigations.

Downloads

Download data is not yet available.

References

Donike M, Barwald KR, Klostermann K, Schanzer W, Zimmermann J. Nachweis von exogenen Testosteron. In: Heck H, Hollmann W, Liesen H eds. Sport: Leistung und Gesundheit. Köln, Germany, 1983: 293–8.

Johnson MD. Steroids. Adolescent Med 1991 Feb; 2: 79–93.

Goldfien A. The gonadal hormones & inhibitors. In: ed. Basic and clinical pharmacology. Norwalk, CT: Appleton & Lange, 1987: 461–83.

Ruzicka L, Goldberg MW, Rosenberg HR. Sexualhormone X. Herstellung des 17-Methyltestosteron und anderer Androsten und Androstanderivate. Zusammenhange zwischen chemischer Konstution und männlicher Hormonwirkung. Helv Chim Acta 1935; 18: 1487–98.

Vischer E, Meystre C, Wettstein A. Herstellung weiterer 1-Dehydrosteroide auf mikrobiologischen Wege. Helv Chim Acta 1955; 38: 1502–6.

Meystre C, Frey H, Voser W, Wetstein A. Gewinnung von 1,4-Bisdehydro-3oxo-steroiden. Helv Chim Acta 1956; 39: 734–42.

Brown TR, Spinola-Castro A, Berkovitz GD. Androgen receptor in cultured human testicular fibroblasts. J Clin Endocrinol Metab 1985; 61: 134–41.

Slaunwhite WR, Sandberg AA. Metabolism of 4-14C-testosterone in human subjects. III. Fate of androsterone and etiocholanolone. J Clin Endocrinol Metab 1958; 18: 1056–66.

Baulieu EE, Mauvais-Jarvis F. II. Metabolism of testosterone-4-14C and androst-4-ene-3,17-dione-1,2-3H. J Biol Chem 1964; 239: 1083–9.

Mauvais-Jarvis F, Floch HH, Bercovici JP. Studies on testosterone metabolism in human stubjects with normal and pathological sexual differentiation. J Clin Endocrinol Metab 1968; 28: 460–71.

Zumoff B, Bradlow HL, Finkelstein J, Boyar RM, Hellman L. The influence of age and sex on the metabolism of testosterone. J Clin Endocrinol Metab 1976; 42: 703–6.

Kochakian CD. A steroid review. Metabolite of testosterone: significance in the vital economy. Steroids 1990; 55: 92–7.

Rendic S. Metabolism of testosterone. In: Donike M ed. Proceedings of the 10th Cologne workshop on dope analysis, 1992. Cologne: Sport und Buch Strauss, 1993: 27–47.

Agiulera R, Hatton CK, Catlin DH. Detection of epitestosteron doping by isotope ratio mass spectrometry. Clin Chem 2002; 48: 629–36.

Auterhoff, Knabe, Holtje. Lehrbuch der pharmazeutischen Chemie. Stuttgart: Wissenschaftliche Verlagsessellschaft mbH, 1994: 793–4.

Dorland’s Illustrated Medical Dictionary.

Rocha-Monteiro P, Reis-Henriques M, Coimbra J. Polycyclic aromatic hydrocarbons inhibit in vitro ovarian steroidogenesis in the flounder (Platichthys flesus L.). Aquatic Toxicol 2000; 48: 549–59.

Strauss RH. Anabolic steroids. In: ed. Drugs and performance in sports. Philadelphia: W. B. Saunders, 1987: 5: 59–67.

Yesalis CE, Wright JE, Bahrke MS. Epidemiological and policy issues in the measurement of the long term health effects of anabolic-androgenic steroids. Sports Medicine 1989; 8: 129–38.

Kibble MW, Ross MB. Adverse effects of anabolic steroids in athletes. Clinical Pharmacy 1987; 6: 686–92.

Brower KJ, Catlin DH, Blow FC, Eliopulos GA, Beresford TP. Clinical assessment and urine testing for anabolic-androgenic steroid abuse and dependence. American Journal Of Drug And Alcohol Abuse 1991; 17: 161–71.

Dehennin L, Matsumoto AM. Long-term administration of testosterone enanthanate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport. J Steroid Biochem Mol Biol 1993; 44: 179–89.

How to Cite
1.
Osredkar J. ENDOCRINE EVALUATION OF ATHLETE FOR TESTOSTERONE OR ITS ANALOGUES ABUSE. SlovMedJour [Internet]. 1 [cited 9Dec.2018];72(12). Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/1892
Section
Review